Table 2 Multiple analyses.
| Risk factor | Outcome 1 (ventilation time) | Outcome 2 (death) | ||
|---|---|---|---|---|
| Regression coefficient (95% CI) | p Value | Odds ratio (95% CI) | p Value | |
| Cardiovascular compromise | 1.46 (1.08 to 1.99) | 0.02 | 5.68(2.04 to 15.84) | <0.01 |
| End organ dysfunction | 1.36 (1.18 to 1.57) | <0.01 | 1.22 (0.85 to 1.76) | 0.28 |
| Syndrome or associated problem | 1.34 (1.12 to 1.61) | <0.01 | N/A | N/A |
| CHD type | ||||
| LHO versus PA | 0.79 (0.53 to 1.19) | 0.27 | 1.06 (0.18 to 6.25) | 0.95 |
| TGA versus PA | 1.98 (1.32 to 2.97) | <0.01 | 1.82 (0.30 to 11.08) | 0.51 |
| SV versus PA | 1.54 (0.88 to 2.69) | 0.13 | 27.03 (4.59 to 159.16) | <0.01 |
| TAPVC versus PA | 2.31 (1.26 to 4.22) | <0.01 | 2.79 (0.42 to 18.55) | 0.29 |
| Other versus PA | 1.18 (0.73 to 1.90) | 0.50 | 2.67 (0.44 to 16.28) | 0.29 |
| 1/patient admit age | NA | NA | 1.13 (0.88 to 1.44) | 0.33 |
CHD, congenital heart disease; LHO, left heart obstruction; NA, not applicable; PA, pulmonary atresia; SV, single ventricle with arch obstruction; TAPVC, total anomalous pulmonary venous connection; TGA, transposition of the great arteries.